highperformr logo

Artiva Biotherapeutics's Overview

Total employees94
HeadquartersLa Jolla
Founded2019

Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing off-the-shelf, allogeneic natural killer (NK) cell therapies to treat cancer. Their mission is to harness the power of the innate immune system to provide more effective and accessible cancer treatments. Artiva is advancing a pipeline of NK cell therapies, including AlloNK® (AB-101) and CAR-NK candidates like AB-201, designed to be readily available for patients and overcome limitations of autologous cell therapies.

Where is Artiva Biotherapeutics's Headquarters?

HQ Function

The headquarters serves as the central hub for Artiva's research and development, clinical operations, corporate strategy, and administrative functions, driving the company's mission to develop novel NK cell therapies.

Notable Features:

Located within a modern biotech park, the facility likely includes state-of-the-art laboratory spaces for cell therapy research, process development, and quality control, alongside corporate offices.

Work Culture:

Artiva fosters a highly collaborative, innovative, and science-driven work culture. The environment is focused on advancing cutting-edge therapies with a strong sense of urgency, teamwork, and a patient-centric mission.

HQ Significance:

The San Diego headquarters is strategically positioned within a vibrant ecosystem of world-class research institutions, numerous biotech companies, and a rich talent pool, facilitating collaborations and accelerating innovation in cancer immunotherapy.

Values Reflected in HQ: The headquarters likely reflects Artiva's core values of scientific excellence, innovation, integrity, and collaboration, providing an environment conducive to groundbreaking research and development of transformative cancer therapies.

Location:

While Artiva Biotherapeutics is headquartered in the United States, it maintains a significant global dimension through strategic partnerships, most notably with GC Cell in South Korea for the development, manufacturing, and commercialization of its NK cell therapies in Asia. The company's clinical trials are often designed for international participation to reach diverse patient populations, and its investor base includes international entities, reflecting its global outlook in addressing cancer.

Street Address:

9310 Athena Circle, Suite 200

City:

La Jolla

State/Province:

CA

Country:

USA

Artiva Biotherapeutics's Global Presence

Buying Intent Signals for Artiva Biotherapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Artiva Biotherapeutics

As of April 2025, Artiva Biotherapeutics' leadership includes:

Fred Aslan, M.D. - President & Chief Executive Officer
Peter Flynn - Chief Operating Officer
Jason Litten, M.D. - Chief Medical Officer
Ahmad R. Termechi, Ph.D. - Chief Development Officer
Sarah McCabe - Chief Financial Officer
Eugene Y. Lee, M.S., J.D. - Chief Business Officer
Jennifer K. Bush - Chief People Officer

Investors of Artiva Biotherapeutics

Artiva Biotherapeutics has been backed by several prominent investors over the years, including:

5AM Ventures
Cormorant Asset Management
venBio Partners
RA Capital Management
Acuta Capital
Surveyor Capital (a Citadel company)
Logos Capital
Janus Henderson Investors
RTW Investments, LP
GC (Green Cross Holdings)
Medivate Partners

Executive New Hires/Exits in the Last 12 Months

Hire3
Exits0

Over the past 12 months, Artiva Biotherapeutics has significantly strengthened its leadership team with key appointments in finance, development, and human resources, underscoring its commitment to growth and advancing its clinical pipeline. No notable executive departures were publicly announced during this period.

New Appointments:

Sarah McCabe, Sarah McCabe appointed as new Chief Financial Officer, bringing extensive biopharmaceutical financial expertise to lead Artiva's financial strategy and operations.
Ahmad R. Termechi, Ph.D., Ahmad R. Termechi, Ph.D., joined as Chief Development Officer to spearhead product development strategies and execution for Artiva's NK cell therapy pipeline.
Jennifer K. Bush, Jennifer K. Bush appointed as Chief People Officer to lead human resources, talent management, and organizational development initiatives.

Technology (Tech Stack) used by Artiva Biotherapeutics

Discover the tools Artiva Biotherapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Artiva Biotherapeutics Email Formats and Examples

While Artiva Biotherapeutics does not publicly disclose its specific email format structure, a common pattern observed in many biotechnology companies is the [first_initial][last]@[companydomain.com] format. Other possibilities include [first].[last]@[companydomain.com].

[first_initial][last]@artivabio.com

Format

jdoe@artivabio.com

Example

75%

Success rate

News and media

Artiva Biotherapeutics Website (via PR Newswire)January 8, 2024

Artiva Biotherapeutics Appoints Sarah McCabe as Chief Financial Officer

Artiva Biotherapeutics announced the appointment of Sarah McCabe as its new Chief Financial Officer. Ms. McCabe brings over 20 years of financial leadership experience in the biopharmaceutical industry to Artiva....more

Artiva Biotherapeutics Website (via PR Newswire)December 11, 2023

Artiva Biotherapeutics Presents Updated Clinical Data from Phase 1/2 Study of AlloNK® (AB-101) in Combination with Rituximab in Relapsed/Refractory B-Cell NHL at the 2023 ASH Annual Meeting

Artiva shared encouraging updated clinical data from its Phase 1/2 study of AlloNK® (AB-101), an allogeneic NK cell therapy, in combination with rituximab for patients with relapsed/refractory B-cell non-Hodgkin lymphoma. The data highlighted positive efficacy and safety profiles....more

Artiva Biotherapeutics Website (via PR Newswire)August 2, 2023

Artiva Biotherapeutics Strengthens Leadership Team with Appointments of Ahmad Termechi, Ph.D., as Chief Development Officer and Jennifer Bush as Chief People Officer

Artiva announced significant additions to its executive team with Ahmad Termechi, Ph.D., joining as Chief Development Officer and Jennifer Bush as Chief People Officer, aiming to bolster the company's development capabilities and human resources functions....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Artiva Biotherapeutics, are just a search away.